NYSE:RFL Rafael (RFL) Stock Price, News & Analysis $1.74 -0.01 (-0.29%) As of 12:12 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Rafael Stock (NYSE:RFL) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Rafael alerts:Sign Up Key Stats Today's Range$1.73▼$1.7850-Day Range$1.30▼$2.8452-Week Range$1.28▼$3.19Volume16,918 shsAverage Volume139,555 shsMarket Capitalization$61.23 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Rafael Holdings, Inc. primarily engages in holding interests in clinical and early-stage pharmaceutical companies, and commercial real estate assets in the United States and Israel. It operates in two segments, Healthcare and Real Estate. The company engages in the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. Its lead drug candidate is CPI-613 (devimistat), currently under Phase III clinical study for the treatment of metastatic pancreatic cancer and acute myeloid leukemia. The company is also involved in developing Promitil, a molecule designed for the targeted delivery of mitomycin-C in a proprietary prodrug form, completed Phase 1B clinical studies; Folate-targeted Promitil (Promi-Fol) which is aimed at local treatment (intravesical) of superficial bladder cancer; and Promi-Dox, a highly potent dual drug liposome with MLP and doxorubicin targeting a potential basket of tumors. In addition, it engages in the development of surgical and procedural devices, including orthopedic arthroscopy instrumentation. Rafael Holdings, Inc. was incorporated in 2017 and is headquartered in Newark, New Jersey. Read More Rafael Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks17th Percentile Overall ScoreRFL MarketRank™: Rafael scored higher than 17% of companies evaluated by MarketBeat, and ranked 857th out of 919 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for Rafael. Earnings and Valuation0.6 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Rafael is -1.85, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Rafael is -1.85, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioRafael has a P/B Ratio of 0.50. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.51% of the outstanding shares of Rafael have been sold short.Short Interest Ratio / Days to CoverRafael has a short interest ratio ("days to cover") of 0.7, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Rafael has recently increased by 6.57%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldRafael does not currently pay a dividend.Dividend GrowthRafael does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted0.51% of the outstanding shares of Rafael have been sold short.Short Interest Ratio / Days to CoverRafael has a short interest ratio ("days to cover") of 0.7, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Rafael has recently increased by 6.57%, indicating that investor sentiment is decreasing significantly. News and Social Media1.0 / 5News Sentiment-0.13 News SentimentRafael has a news sentiment score of -0.13. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.46 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Rafael this week, compared to 22 articles on an average week.Search InterestOnly 1 people have searched for RFL on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days. Company Ownership2.5 / 5Insider TradingAcquiring Shares Insider Buying vs. Insider SellingIn the past three months, Rafael insiders have bought more of their company's stock than they have sold. Specifically, they have bought $16,742,985.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders10.20% of the stock of Rafael is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 11.30% of the stock of Rafael is held by institutions.Read more about Rafael's insider trading history. Receive RFL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Rafael and its competitors with MarketBeat's FREE daily newsletter. Email Address RFL Stock News HeadlinesWall Street Zen Downgrades Rafael (NYSE:RFL) to SellAugust 2 at 3:13 AM | americanbankingnews.comNew Photo of Rafael Nadal and Roger Federer Emerges on TuesdayJuly 26, 2025 | msn.comThis rock I’m holding could be worth trillionsA strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materials critical for AI chips, EV batteries, smartphones, and advanced weapons systems. While few people know about these metals, global powers—including the U.S., China, and Russia—are racing to secure them. And one tiny public company, recently backed by the U.S. government, holds mining rights to over 340 million tons… and near-monopoly access to the richest zone.August 4 at 2:00 AM | Porter & Company (Ad)Rafael Leao pays heartfelt tribute to Diogo Jota as Milan beat LiverpoolJuly 26, 2025 | msn.comRafael Leao, Kenny Dalglish and Hong Kong crowd honor Diogo Jota in Liverpool preseason friendlyJuly 26, 2025 | msn.comRafael Leao's touching tribute to Diogo Jota vs Liverpool as club make statementJuly 26, 2025 | mirror.co.ukMRafael Devers Player Props: July 25, Giants vs. MetsJuly 25, 2025 | sportsbookwire.usatoday.comWatch: Roger Federer visits Rafael Nadal's AcademyJuly 18, 2025 | msn.comSee More Headlines RFL Stock Analysis - Frequently Asked Questions How have RFL shares performed this year? Rafael's stock was trading at $1.65 at the start of the year. Since then, RFL stock has increased by 5.8% and is now trading at $1.7450. How were Rafael's earnings last quarter? Rafael Holdings, Inc. (NYSE:RFL) released its quarterly earnings data on Wednesday, June, 11th. The company reported ($0.19) earnings per share for the quarter. The firm earned $0.36 million during the quarter. Rafael had a negative net margin of 3,127.60% and a negative trailing twelve-month return on equity of 24.75%. How do I buy shares of Rafael? Shares of RFL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Rafael own? Based on aggregate information from My MarketBeat watchlists, some other companies that Rafael investors own include NVIDIA (NVDA), Broadcom (AVGO), CrowdStrike (CRWD), ServiceNow (NOW), Adobe (ADBE), Arista Networks (ANET) and e.l.f. Beauty (ELF). Company Calendar Last Earnings6/11/2025Today8/04/2025Fiscal Year End7/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry MED - DRUGS Sub-IndustryReal Estate Current SymbolNYSE:RFL CIK1713863 Webwww.rafaelholdings.com Phone(212) 658-1450FaxN/AEmployees20Year FoundedN/AProfitability EPS (Trailing Twelve Months)($0.94) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$34.41 million Net Margins-3,127.60% Pretax Margin-3,539.48% Return on Equity-24.75% Return on Assets-21.12% Debt Debt-to-Equity RatioN/A Current Ratio3.85 Quick Ratio3.82 Sales & Book Value Annual Sales$640 thousand Price / Sales95.95 Cash FlowN/A Price / Cash FlowN/A Book Value$3.51 per share Price / Book0.50Miscellaneous Outstanding Shares35,090,000Free Float31,511,000Market Cap$61.41 million OptionableOptionable Beta0.99 Social Links The Best Nuclear Energy Stocks to BuyNuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.Get This Free Report This page (NYSE:RFL) was last updated on 8/4/2025 by MarketBeat.com Staff From Our PartnersBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredGenesis 14:13-17 [HIDDEN MEANING?]A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...Paradigm Press | SponsoredOut with the old (A.I.) - In with the new (E.I.)One expert predicts that E.I. could see over 200,000% growth... But you need to move fast...Behind the Markets | SponsoredI’d rather trade news like this than gamble on hypeReal traders are watching Nvidia’s next move—after U.S. approval to resume chip sales to China. This reversal ...Timothy Sykes | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredOne stock to replace NvidiaInvesting Legend Hints the End May be Near for These 3 Iconic Stocks One company to replace Amazon… another...InvestorPlace | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rafael Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Rafael With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.